None listed
Conditions
Sponsors
KSO Corporation
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1) Males aged 20 to 64 years-old. (2) Subjects whose serum uric acid levels are 5.9 mg/dL to 7.9 mg/dL by the screening tests, however, more than half of all subjects have a serum uric acid level of 7.0 mg/dL or less. (3) Subjects who can make self-judgment and are voluntarily giving written informed consent.
Exclusion criteria
Exclusion criteria: Subjects (who) (1) are judged hyperuricemia in need of treatment and are under treatment. (2) whose serum creatinine levels are 1.3 mg/dL or over by the screening tests. (3) have a history of and/or contract serious diseases (eg, liver and kidney disease, digestive disease, heart disease, endocrine disease, thyroid disease, adrenal disease and/or metabolic disease). (4) contract chronic disease and are under treatment. (5) are judged as unsuitable for the current study by the investigator through the screening tests. (6) have a history and/or a surgical history of digestive disease affecting digestion and absorption. (7) whose BMI are 30 or more. (8) declared allergic reactions to foods. (9) can't stop using medicines, quasi-drugs, supplements and/or functional foods (including Food for Specified Health Uses or Foods with Function Claims) affecting serum uric acid during test periods. (10) have excessive alcohol intake more than approximately 60 g/day of pure alcohol equivalent or a habit of drinking not less than 5 days a week. (11) can't stop drinking and intense exercise from 2 days before each measurement. (12) can't stop ingestion of meals other than designated meals from a day before each measurement. (13) have donated over 200 mL of blood and/or blood components within the last one month prior to the current study or over 400 mL of blood and/or blood components within the last three months prior to the current study. (14) have a history of and/or contract drug addiction and/or alcoholism. (15) are planning to participate and/or had participated in other clinical studies within the last one month prior to the current study. (16) are judged as unsuitable for the current study by the investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum uric acid and change in uric acid | — |
Countries
Japan
Contacts
Public ContactYoshika Komori
KSO Corporation Sales department
Outcome results
None listed